approved
Metabolik & berat badan
Nama komersialOzempic®, Wegovy®, Rybelsus®
Nama popular / stackTiada nama stack standard — dikenali dengan nama bahan atau kajian
KegunaanType 2 diabetes, chronic weight management and product-specific approved indications.
Reseptor / sasaranGLP-1 receptor (GLP-1R) agonist.
Status regulatorFDA-approved active ingredient in products including Ozempic, Rybelsus and Wegovy. Approval applies only to the registered product and formulation.
Cycle / tempohLong-term prescription treatment; injectable products are generally once weekly with label-directed titration.
WaktuUse on the same day each week; label permits any time of day, with or without meals.
approved
Metabolik & berat badan
Nama komersialMounjaro®, Zepbound®
Nama popular / stackTiada nama stack standard — dikenali dengan nama bahan atau kajian
KegunaanType 2 diabetes and chronic weight management under product-specific labels.
Reseptor / sasaranDual GIP receptor and GLP-1 receptor agonist.
Status regulatorFDA-approved in Mounjaro and Zepbound for different indications. Approval applies only to those registered products.
Cycle / tempohLong-term prescription treatment, generally once weekly with clinical titration.
WaktuUse on the same day each week according to the product label.